Article
Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants.
Annals of the rheumatic diseases - 1 Feb 2018
Rönnelid Johan, Hansson Monika, Mathsson-Alm Linda, Cornillet Martin, Reed Evan, Jakobsson Per-Johan, Alfredsson Lars, Holmdahl Rikard, Skriner Karl, Serre Guy, Lundberg Karin, Klareskog Lars
Abstract excerpt
INTRODUCTION: The second generation anticycliccitrullinated peptide (anti-CCP2) assay detects the majority but not all anticitrullinated protein/peptide antibodies (ACPA). Anti-CCP2-positive rheumatoid arthritis (RA) is associated with HLA-DRB1* shared epitope (SE) alleles and smoking. Using a multiplex assay to detect multiple specific ACPA, we have investigated the fine specificity of individual ACPA responses...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
